结膜状细胞癌的基于下一代测序的分子分析及其对治疗的潜在应用
Hakan Demirci1, Josh N Vo2, Yi-Mi Wu2
1Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan.
Ophthalmology science
|June 18, 2025
概括
结膜状细胞癌 (cSCC) 主要是由TP53的改变和紫外线信号驱动的,而不是HPV. 高瘤突变负担表明免疫疗法是cSCC的可行的治疗选择.
科学领域:
- 眼科医生 眼科 眼科
- 在瘤学瘤学.
- 基因组学就是基因组学.
背景情况:
- 结膜状细胞癌 (cSCC) 是一种罕见的眼睛表面恶性瘤.
- 了解cSCC的分子驱动因素对于开发向疗法至关重要.
研究的目的:
- 对侵入性cSCC进行全面的基因组和转录组分析.
- 确定cSCC中的关键分子变化和潜在的治疗点.
主要方法:
- 针对>1700个与癌症相关的基因的下一代测序.
- 从瘤和正常样本中对外体和转录体数据的综合分析.
- 分子特征包括体质突变,瘤突变负担 (TMB),结构变异和基因表达.
主要成果:
- 人类乳头瘤病毒 (HPV) 在20个cSCC中仅在2个检测到.
- 在HPV阴性瘤中,TP53和CDKN2A的改变很常见;在HPV阳性瘤中发现了PIK3CA突变.
- 在65%的病例中观察到高TMB (>20 Mut/Mb),通常与UV突变特征和TERT促进子突变相关.
- 还发现了反复出现的副本编号变化和异常TP63表达.
结论:
- 在这个队列中,HPV不是cSCC的主要驱动因素.
- 在HPV阴性cSCC中,TP53的改变和紫外线信号是关键因素.
- 染色体修饰剂,Hippo和Notch通路基因经常受到改变.
- 高TMB和可操作的分子标表明免疫疗法和向疗法是潜在的治疗策略.
相关概念视频
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...